182 filings
Page 3 of 10
8-K
9fx2najn
7 Dec 22
Regulation FD Disclosure
7:37am
8-K
7ma w9ww2
8 Nov 22
AVROBIO Reports Third Quarter 2022 Financial Results and Provides Business Update
7:15am
8-K
0gybfd estssn
7 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K
b8x q4l3rrm
9 Aug 22
AVROBIO Reports Second Quarter 2022 Financial Results and Provides Business Update
7:11am
S-8
0pdr f5iyxdk0yyu5n1
9 Aug 22
Registration of securities for employees
12:00am
8-K
k00tzy3 jzabk7tnr
29 Jun 22
Departure of Directors or Certain Officers
4:30pm
8-K
whk30p yy89
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
e164f395gkq
24 May 22
Regulation FD Disclosure
7:00am
8-K
ut5m1bf zge82j
18 May 22
AVROBIO Announces Preclinical Gene Therapy Data for Pompe Disease at American Society of Gene and Cell Therapy (ASGCT) annual meeting
8:30am
8-K
lijqsgd
17 May 22
AVROBIO Reports Positive Data from Phase 1/2 Clinical Trial of Investigational
7:12am
8-K
ieqx99inmjuvz5
10 May 22
AVROBIO Reports First Quarter 2022 Financial Results and Provides Business Update
7:05am
DEFA14A
fuconv a7h
27 Apr 22
Additional proxy soliciting materials
5:03pm
S-8
ok5j 8tya34a9
17 Mar 22
Registration of securities for employees
4:56pm
8-K
m0b2b1e3fwk7w rw
17 Mar 22
AVROBIO Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
7:54am